WEI HU to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications WEI HU has written about Receptors, Vascular Endothelial Growth Factor.
Connection Strength
0.023
-
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Dec; 127(3):538-43.
Score: 0.023